Simplified kinetic modeling for predicting the stability of complex biotherapeutics

Area of Science:

• Biopharmaceutical Development
• Chemical Kinetics
• Protein Stability

Background:

• Biologics stability studies are essential for formulation, packaging, and shelf-life determination.
• Predicting long-term stability from short-term data is challenging due to complex biologic behavior.

Purpose of the Study:

• To develop and validate a simple kinetic model for predicting protein aggregate formation in various biologics.
• To assess the model's accuracy and reliability compared to traditional methods like linear extrapolation.

Main Methods:

• Utilized a first-order kinetic model combined with the Arrhenius equation for stability predictions.
• Applied the model to diverse protein modalities including IgG1, IgG2, bispecific IgG, Fc fusion, scFv, nanobodies, and DARPins.
• Investigated the impact of temperature selection on identifying dominant degradation pathways.

Main Results:

• The first-order kinetic model accurately predicted long-term stability and protein aggregate formation across various protein formats.
• Optimal temperature selection was found to be significant for identifying key degradation processes.
• The kinetic model demonstrated superior precision and accuracy compared to linear extrapolation, especially with limited data.

Conclusions:

• Simple kinetic modeling offers a reliable and efficient approach for predicting protein aggregate stability in biologics.
• This method aids in optimizing formulation, packaging, and shelf-life determination for biopharmaceuticals.
• The model's broad applicability across different protein formats underscores its value in biopharmaceutical development.